# Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

Study · id `cardio:ct-nct06765356` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06765356](<https://clinicaltrials.gov/study/NCT06765356>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06765356

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 275 participants.

## Technical summary

Registry record NCT06765356. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-15 (actual); primary completion 2027-03-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 275 participants (enrolled count; ClinicalTrials.gov record NCT06765356, source copy `cardio:ctgov-nct06765356-2026-04-14`, retrieved 2026-10-26)
- Started: 2025-04-15 (actual) (ClinicalTrials.gov record NCT06765356, source copy `cardio:ctgov-nct06765356-2026-04-14`, retrieved 2026-10-26)
- Primary completion: 2027-03-30 (anticipated) (ClinicalTrials.gov record NCT06765356, source copy `cardio:ctgov-nct06765356-2026-04-14`, retrieved 2026-10-26)
- Completion: 2027-03-30 (anticipated) (ClinicalTrials.gov record NCT06765356, source copy `cardio:ctgov-nct06765356-2026-04-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06765356, source copy `cardio:ctgov-nct06765356-2026-04-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06765356-2026-04-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
- Acronym: PROSPECT
- Condition: Persistent Atrial Fibrillation
- Condition: Paroxysmal Atrial Fibrillation
- Condition: Long-standing Persistent Atrial Fibrillation
- Intervention (Device): Farapulse Catheter System
- Intervention (Drug): Low-dose Colchicine
- Lead sponsor: Vivek Reddy
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Vivek Reddy (`cardio:org-vivek-reddy`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: ad203c13fdc711639277fdead3b454853d93d37d71b79ce81121db5c7d4a6fc2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
